Background Since antidepressants are prescribed for multiple indications, the use of an antidepressant cannot be equated with a diagnosis of depression. Objective The objective of this study was to examine the quality of antidepressant prescribing in Belgian nursing homes, with a critical evaluation of indications and dosages, to see whether depression was appropriately treated in terms of drug choice, the indications for which antidepressants were being prescribed and whether there was underdosing. Methods This analysis was based on data obtained in the Prescribing in Homes for the Elderly in Belgium (PHEBE) study, a cross-sectional, descriptive study of a representative, stratified, random sample of 1,730 residents from 76 Belgian nursing homes. The PHEBE study investigated overall drug utilization in Belgian nursing homes in 2006. Clinical and medication data for the present study were obtained from this study. A 28-item checklist of clinical conditions was designed ad hoc for the PHEBE study and sent to the residents' general practitioners (GPs) to collect clinical information. We copied the residents' medication charts, classified the drugs using the Anatomical Therapeutic Chemical (ATC) classification system codes and transferred the drug names and dosages into a database. Information on indications was retrospectively obtained from the GPs, so that we could link the indication to each medication. Minimum effective doses (MEDs) of antidepressants to treat major depression were obtained from the literature to assess underdosing. Results The overall use of antidepressants in nursing homes was 39.5 % (95 % CI 37.2, 41.8). The physicians classified 34.2 % (95 % CI 32.0, 36.4) of the residents as having depression, and 80.9 % of these patients were treated with an antidepressant. Indications among the single antidepressant users (n = 551) were depression (66.2 %), insomnia (13.4 %), anxiety (6.2 %) and neuropathic pain (1.6 %). In the indication of depression, 74.8 % used a selective serotonin reuptake inhibitor (SSRI), predominantly citalopram, sertraline and escitalopram. Venlafaxine was used by 10.7 % of the residents. Dosages for these antidepressants were equal to or higher than the MED. But when trazodone, amitriptyline or mirtazapine were used to treat depression, respectively, 92.3, 55.5 and 44.5 % of prescribed dosages were below the MED. In the indication of insomnia, most of the time, trazodone (90.5 %) or mirtazapine (5.4 %) were used, and in lower dosages than those required for depression treatment (\MED). Tricyclic antidepressants were predominantly used for the treatment of neuropathic pain and were also used at lower dosages. Of all the residents receiving a medication for anxiety, only 13.9 % received an antidepressant (mostly an SSRI), and the remaining received a benzodiazepine. Conclusions The number one indication for the use of an antidepressant was depression. Within this indication, mostly the recommended SSRIs were used, in dosages equal to or higher than the MED. Furthermore, we noticed
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Introduction
The prevalence of late-life depression in nursing homes varies from 11 to 50 % [1] [2] [3] [4] [5] and is generally higher than that in community-dwelling older adults [6] . Depression is often reported to be under-recognized and undertreated in older adults [3, 7] . However, the use of antidepressants has increased over the last decade [8] , and this trend was also visible in the nursing home population [9, 10] .
Depression often has an atypical presentation in older adults [11] . The poor recognition of clinical features of depression in old age and the overlap with symptoms of dementia or other comorbidities makes a correct diagnosis difficult.
Depression negatively affects daily activities [12] and quality of life [13] , causes high treatment and societal costs [14, 15] and increases mortality [16] . Chronic diseases, pain and social deprivation are known risk factors for developing depression [17] . These elements are common in long-term care facilities. Moreover, transition from the community to a nursing home can trigger depression, which results in a high number of newly admitted residents developing depression [2, 18] .
Depression is a treatable illness [19] ; approximately 50-60 % of patients with a major depressive disorder are thought to improve clinically as a consequence of antidepressant treatment [20, 21] . In addition, there are other indications for antidepressants. Anxiety, panic disorders, behavioural and psychological symptoms of dementia, and neuropathic pain [22] are potential indications for antidepressants in the older population. In daily practice, antidepressants are also prescribed for insomnia without concomitant depressive symptoms, although this indication is not mentioned in the official labelling [23] .
In order to make a complete evaluation of antidepressant prescribing attitudes and to evaluate the pharmacotherapy of depression, both indication and dosage information are necessary. Drug utilization studies that evaluate the indication and dosages of these medications are scarce [24] [25] [26] . In these studies, indication analysis is mostly done by linking clinical diagnoses [International Classification of Diseases, Ninth Revision (ICD-9) or Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM IV)] and medication databases. This does not automatically provide information on the reason or the indication for which each antidepressant was prescribed. Similar to the BEACH (Bettering the Evaluation And Care of Health) project in Australia [27] , the PHEBE (Prescribing in Homes for the Elderly in Belgium) study was designed to include the indication per medication as reported by the prescribing general practitioner (GP). The PHEBE study was a cross-sectional, descriptive study of a representative, stratified, random sample of 76 Belgian nursing homes and investigated overall drug utilization in Belgian nursing homes in 2006. A detailed description of the methods and findings of this study has been published elsewhere [28] [29] [30] .
The main objective of this sub-analysis of the data obtained in the PHEBE study was to examine the quality of antidepressant prescribing in Belgian nursing homes, with a critical evaluation of indications and dosages, to see whether depression was appropriately treated in terms of drug choice, the indications for which antidepressants were being prescribed and whether there was underdosing. An additional objective was to investigate the resident characteristics associated with antidepressant use.
Methods

Setting
Belgium has a mixed public/private healthcare system. The system works on a fee for service basis. The Belgian longterm residential care structure consists of residential and/or nursing homes for older people, which offer a home replacement with or without nursing care. Governance of nursing homes for older people is either public (community health services) or private (predominantly nonprofit), with little difference in quality. In Belgian nursing homes, residents are still supervised by their own GP, and this leads to an average of 32 GPs per nursing home.
Data Collection
In the PHEBE study, data collection at the resident level included administrative, clinical and medication data. We obtained the medication data by copying the resident's medication chart, coding it and transferring it to a database. To collect clinical data, we sent the residents' GPs a checklist with 28 items, which focused on clinical problems (i.e. cardiovascular disease, chronic obstructive pulmonary disease, peptic ulcer) and care problems (i.e. problems with a predominant nursing care burden, such as dementia, insomnia, depression, etc.). The 28-item checklist of clinical conditions was designed ad hoc for this study, with the items selected on the basis of existing prescribing quality indicators [Beers' [31] , Assessing Care of the Elderly (ACOVE) [32] , Bergen District Nursing Home Study (BEDNURS) [33] criteria] for older adults.
The diagnosis of depression in this study was based on the clinical evaluation conducted by the GP. In Belgium, the Katz scale is a mandatory instrument in nursing homes, and it consists of two parts. The first part scores activities of daily living and the second part scores disorientation in time and place. This second part is scored from 1 (no disorientation) to 5 (severe disorientation) and was used as a proxy by GPs and nursing staff to estimate the severity of dementia in this study. Residents receiving palliative care were excluded from the analysis.
Classification of Antidepressants
Antidepressants were classified according to the Anatomical Therapeutic Chemical (ATC) classification system [34] . According to the availability of drugs on the Belgian pharmaceutical market, we investigated the classes N06AA tricyclic antidepressants (TCAs), N06AB selective serotonin reuptake inhibitors (SSRIs), N06AG monoamino oxidase inhibitors (MAOIs) and the class N06AX, which includes serotonin-norepinephrine reuptake inhibitors (SNRIs) and other antidepressants.
The SNRIs duloxetine and bupropion are not included in the analysis because they were not yet commercialized in Belgium in 2006. Lithium, which in the ATC classification system is considered an antipsychotic and which is mostly used to treat bipolar disorders, was excluded from analysis. Combination drugs comprising an antidepressant and an antipsychotic were also excluded. Duplicate use therapy was defined as the concomitant use of two or more antidepressants. Medications that were prescribed for shortterm use and as-needed medications were excluded from the analysis. We focused on chronic use (defined as daily use for at least 3 months).
We analysed two levels of information regarding antidepressant use: the prescription (medication) level and the resident level. Indications were analysed at the prescription and resident levels and dosages at the prescription level only.
Indication and Dosages
Data on indications were collected retrospectively; the GP received a printout of the resident's medication chart for verification of the medications used, and he/she was asked to tick the relevant indications for antidepressants from a predefined list: depression, posttraumatic stress, anxiety, insomnia, neuropathic pain or other.
The prescribed daily dose (PDD) of each antidepressant was recorded by summing the doses taken at the different moments of intake during 1 day. To interpret these doses, we chose the universal defined daily dose (DDD), which is the assumed average maintenance dose per day for a drug used for its main indication in adults [34] . We described the distribution of the PDD using its median and range. To examine possible underdosing in the treatment of depression, we used the minimum effective dose (MED). The MED of an antidepressant serves as a threshold, below which all doses are not effective in treating a major depressive episode [35] . The MEDs of the most common antidepressants were determined using Prescribing Guidelines [36] and Pharmacotherapy: A Pathophysiologic Approach [37] . We considered the prescription underdosing when the PDD of the antidepressant was under the MED.
Statistical Analysis
The data was analysed using the statistical package SPSS version 18 (IBM SPSS Statistics, New York, USA). The alpha level of significance was set at p \ 0.05. We used descriptive statistics to explore indications and dosages.
We examined the characteristics (demographical, clinical, medication and institutional information) of the antidepressant users and nonusers, and also compared the characteristics of the antidepressant users for the different indications (respectively for depression and all other indications). To investigate differences, we used the Chisquared (v 2 ) test for discontinuous variables, the t test for continuous variables and non-parametric statistics (the Mann-Whitney U test) for skewed distributions.
In a second analysis, we explored a risk profile for antidepressant use. We calculated the odds ratios (ORs) and the 95 % confidence intervals (CIs) in univariate and multivariate analyses. For multivariate analysis, we used a stepwise regression model including the statistically significant variables from the univariate analysis.
Results
Study Population Characteristics
Medication data and clinical information of 1,730 nursing home residents was included in the analysis. The mean age was 85 (range 60-104) years and 78.1 % of participants were female. The prevalence of depression was 34.2 % (95 % CI 32.0, 36.4). In 14.9 % of the residents, a combination of depression and dementia was noted.
The mean number of chronic medications per resident was seven, and the number ranged from no medication (in less than 1 % of the residents) to 22. The most frequently used drugs among the residents were the central nervous system drugs, with benzodiazepine, antidepressant, antipsychotic and antidementia drug use in, respectively, 53.1, 39.5, 32.9 and 8.3 % of all residents. The demographical and clinical characteristics of the study population are shown in Table 1 .
Antidepressant Use at the Resident Level:
Prevalence and Indications
The prevalence of chronic antidepressant utilization among 1,730 residents was 39.5 % (95 % CI 37.2, 41.8). The use of a single antidepressant was seen in 32.6 %, while concomitant use of two to four antidepressants was found in 6.9 %. Among the antidepressant users using a single antidepressant (n = 551), the leading indication for this use was depression (66.2 %), followed by insomnia (13.4 %), anxiety (6.2 %) and pain (1.6 %). We found the use of a single antidepressant for 'multiple indications' in 11.6 % of residents. This category was used largely for depression associated with another indication ( Table 2 ).
The physicians categorized 34.2 % (95 % CI 32.0, 36.4) of the residents as depressed, and 80.9 % of these patients were treated with an antidepressant; more specific indication analysis showed that 73.1 % of the residents with noted depression received an antidepressant for that very indication (Table 2) . Table 3 shows which antidepressant was most used for which indication. When the indication was depression, 74.8 % of the residents took an SSRI, 10.7 % venlafaxine and 8.2 % mirtazapine. For the single indication 'insomnia' and for the combination of 'insomnia and depression,' 90.5 and 53.3 % of residents, respectively, used trazodone. When the indication was anxiety, different antidepressant classes were used, but mostly SSRIs (64.7 %), trazodone (14.7 %) and venlafaxine (8.8 %) . Of all residents receiving a medication for anxiety, only 13.9 % received an antidepressant (mostly an SSRI) and the remaining patients received a benzodiazepine. The indication of neuropathic pain was mostly treated with a TCA (66.7 %) ( Table 3 ).
Antidepressant Use at the Prescription Level:
Prevalence and Dose Analysis
The most frequently prescribed class of all 814 antidepressant prescriptions was SSRIs (52.8 %), with citalopram, sertraline and escitalopram accounting for, (Table 4) . Of the 814 prescriptions, 72.5 % were indicated for depression. Table 4 shows the frequency of use for all antidepressants and dosing information for the most common antidepressants for this indication. The amount of prescriptions with a PDD below the MED for the treatment of depression was high for trazodone (92.3 %), amitriptyline (55.5 %) and mirtazapine (44.5 %). We did not observe this underdosing when an SSRI or venlafaxine was prescribed.
When we used the DDD as a reference, we saw that for the indication of insomnia, the physicians prescribed daily dosages below the DDD (98.2 %); this was also the case for the treatment of (neuropathic) pain (87.5 %). For anxiety, mostly 1 DDD (53.8 %) or less than 1 DDD was prescribed (46.2 %).
Characteristics Associated with Antidepressant Use
Univariate analysis showed that antidepressant use was significantly associated with polypharmacy, peptic ulcer and some care problems such as depression, insomnia, pain and constipation. We registered a gradual decrease in antidepressant use from the age of 80 years. In a public nursing home and where the medication was dispensed through a hospital pharmacy, there was less antidepressant use (Table 5) .
In Residents who received an antidepressant for the indication of depression had more chronic obstructive pulmonary disease and had a significantly greater usage of (chronic) medication in comparison with the residents that received an antidepressant for other indications. The residents that received an antidepressant for other indications were more likely to be classified by their physician as insomniacs (Table 5) . AD antidepressant, ATC Anatomical Therapeutic Chemical, MAOI monoamino oxidase inhibitor, SNRI serotonin-norepinephrine reuptake inhibitor, SSRI selective serotonin reuptake inhibitor, TCA tricyclic antidepressant a ADs used by B10 residents are not shown: TCA: dosulepine, imipramine, clomipramine, doxepine, nortriptyline, maprotiline; others: mianserine, reboxetine, hypericum perforatum, moclobemide (MAOI) b n = 551 (single AD users corrected for 14 missing indications); the indication 'others' is not shown (n = 5)
Depression and Dementia
In more than one third (34.4 %) of the nursing home residents with some form of dementia, the GP recorded depression. The prevalence of noted depression as well as the use of an antidepressant for the indication 'depression' decreased as dementia progressed. On the other hand, the proportion of residents using antidepressants for other indications slightly increased in patients with more advanced dementia (Fig. 1 ).
Discussion
To our knowledge, our study is the first European study to collect indication and dosage information for each antidepressant directly from the treating physician. Based on the results of this study, depression is not undertreated in Belgian nursing homes. More than one third of Belgian nursing home residents were classified as having depression and 81 % of them were treated with an antidepressant. The prescribing physicians used suitable drug classes according to the guidelines for depression in older people [38] . Underdosing was not seen in the treatment of depression with the most prevalent antidepressant classes, but when antidepressants were used for other indications, we saw the use of lower doses. There was substantial use of antidepressants (mainly trazodone) for insomnia. Furthermore, we noticed physicians were more likely to prescribe a benzodiazepine rather than the preferred SSRIs to treat (chronic) anxiety.
Strengths and Limitations
Our sample proved to be representative both on the institutional and residential levels [39] . Moreover, the large size of our sample makes it possible to extrapolate our findings to the entire Belgian nursing home setting. Similar prevalence numbers for depression and antidepressant use were found in European [1, 40] and American [9] studies, but for specific indication and dosage evaluation, no identical studies were available. The indications for antidepressant prescribing were retrospectively collected by interviewing the GP. As the GP is the prescriber of the antidepressant, this approach gave us a clearer view of the use of antidepressants than linking clinical diagnoses and medication databases would have. This strength can be a limitation as well because of the retrospective aspect of the method. Our interpretation of underdosing and the MED as a threshold was established by using a strict methodology.
A limitation of our study is that we did not collect information about alternative treatment strategies for depression, such as psychotherapy, so we focused our discussion on the residents receiving an antidepressant. Another limitation is that we did not use validated diagnostic criteria to evaluate the severity of depression and dementia; we relied on the a posteriori clinical judgement of the treating physician. The physicians should have been AD antidepressant, ATC Anatomical Therapeutic Chemical, MAOI monoamino oxidase inhibitor, MED minimum effective dose (for depression), PDD prescribed daily dose (for depression), SSRI selective serotonin reuptake inhibitor, TCA tricyclic antidepressant a ADs with B10 prescriptions are not shown: MAOI: moclobemide (n = 1); TCAs: dosulepine (n = 8), imipramine (n = 4), clomipramine (n = 2), doxepin (n = 2), nortriptyline (n = 1), maprotiline (n = 1); others: mianserine (n = 10); reboxetine (n = 5), hypericum (n = 5)
aware that depression is not equal to depressive mood, but we do not know whether they had fully considered this. Moreover, we had no breakdown of various degrees of depression in our checklist of clinical diagnoses. The disorientation axes of the Katz scale may not be an ideal dementia grading instrument as it can be influenced by other disorders (depression, delirium). However, we decided to use this tool for pragmatic reasons; use of the tool is mandatory in the Belgian context, and thus the data are readily available. In addition, in this cross-sectional study, we were not able to investigate the distribution of the duration of antidepressant use; nor was it possible to investigate temporal changes and the relationship between process and outcome. Furthermore, we reduced the complexity of the analysis by narrowing our in-depth analysis of indications to single antidepressant users, and we disregarded residents on more than one antidepressant (6.9 % of all residents).
Main Findings
According to our study, in more than one third of the Belgian nursing home residents, the treating physician noted depression. This percentage is situated in the middle segment of the prevalence range of 11-50 % reported in other studies in different Western countries [1, [3] [4] [5] . Of all the residents classified as having depression, 81 % were treated with an antidepressant and 73 % received an antidepressant especially for the indication 'depression.' Knowing that only major depression should be treated pharmacologically, our results do not support the hypothesis of undertreatment in the group of residents with noted depression. Other recent articles also indicate an antidepressant treatment percentage of more than 80 % [9, 40] for depressed residents, but these percentages are irrespective of indication. In addition to reporting that there is no undertreatment, it could also be useful to examine the reason why about a third of all residents need pharmacological treatment of their depression. In our study, more than one quarter of the antidepressant prescriptions (28 %) were not prescribed to treat depression. Other approved indications such as anxiety and neuropathic pain accounted for 7.8 % of all antidepressant use. Insomnia without depressive symptoms accounted for 13.4 %.
Most of the antidepressants were prescribed at a dosage of 1 DDD or less and rarely exceeded 1 DDD. Possible depression underdosing in the nursing home population was checked by analysing the PDD in accordance with the MED. The SSRI drug group and venlafaxine were prescribed at doses above their MED. Trazodone, TCAs and mirtazapine were often prescribed at doses under their MED. It is important to keep in mind that when treating older adults, polypharmacy, polypathology, pharmacokinetic and pharmacodynamic alterations can influence dosage response. The MED does not really consider these particular changes in determining the threshold. In the literature, there is not much guidance on antidepressants dosing in frail older adults; slow upwards titration and close monitoring of adverse effects is recommended [41] .
Antidepressants for the Indication 'Depression'
For the indication of depression in old age, SSRIs deserve a preference within the pharmacological approach [38, 42] and, as found in our study, were the most commonly prescribed antidepressants in Belgian nursing homes (citalopram, sertraline, escitalopram). Although SSRIs have a more appropriate side effect profile and are safer in overdose for older adults than other antidepressants, still, physicians should prescribe these drugs with caution, because of the risk of drug-drug interactions and adverse effects such as hyponatraemia [43] , upper gastrointestinal bleeding [44] , insomnia, restless leg syndrome, agitation and the potential risk of serotonin syndrome [45, 46] . The Beers list [31] of inappropriate medications for use in older adults includes fluoxetine, because of its long half-life and inhibition of cytochrome P450 enzymes (mainly CYP2D6). In our study, this SSRI was prescribed only in 2 % of the cases.
In our study, venlafaxine was also frequently prescribed for depression. Together with the SSRIs, it is known for its stimulating properties that can cause sleeplessness [47] . Venlafaxine should be reserved as a second-line treatment for depression and is not indicated in patients with heart failure, coronary disease and uncontrolled hypertension [38] .
Mirtazapine is also a relatively often prescribed antidepressant for older adults because it has less anticholinergic adverse effects (i.e. dry mouth, urinary retention, constipation) than TCAs [48] . TCAs, equally effective as SSRIs [49] , are known for their toxicity in overdose [50] and their anticholinergic side effect profile. Therefore, they are not recommended as a first choice to treat depression in older adults. However, a recent cohort study concluded that SSRIs and the newer antidepressants were associated with a higher risk of adverse events, such as stroke, fracture and all-cause mortality, compared with TCAs [40] .
In our study, SSRIs and venlafaxine were prescribed above the MED. However, 45 % of the mirtazapine, 96 % of the trazodone and 56 % of the TCA prescriptions were dosed under their MED, a possible precaution taken by prescribers aware of the sedative and/or anticholinergic properties of these drugs. 
Antidepressants for 'Other Indications'
The most frequently prescribed antidepressant in this setting was trazodone. It was predominately prescribed at lower dosages for primary insomnia. The use of trazodone for sleep disturbance in adult and older patients is extensive in clinical practice [51] . In depressed adult patients, there is evidence for the efficacy of trazodone for sleep disturbance [52] . In non-depressed adult patients, trazodone might be effective in primary insomnia [53] . However, the evidence for its use for primary insomnia in older people is rather scarce [23] and controversial [54] . Trazodone has so far not received approval as a sleeppromoting agent in the official labelling. The adverse effects of trazodone are not very different from other benzodiazepine and non-benzodiazepine hypnotics in terms of residual daytime impairments, but priapism and orthostatic hypotension are important adverse effects of trazodone [55] .
The amount of trazodone prescriptions intended for insomnia and other non-depressive conditions is increasing [51, 56] . The national and international warnings and campaigns against the chronic use of benzodiazepines [15, 57] are a possible reason for the preferential prescribing of trazodone. Another consideration could be the relatively lower cost of trazodone in Belgium in comparison with benzodiazepine and non-benzodiazepine hypnotics. Moreover, trazodone, unlike benzodiazepine and non-benzodiazepine hypnotics, is reimbursed (75 % of the cost) by the Belgium healthcare system. In order to maintain a healthy economic situation, it is important to ensure that no shift towards reimbursed sedative antidepressants takes place, particularly in the absence of convincing evidence.
Another indication for which an antidepressant can be prescribed is neuropathic pain. Our study confirmed the assumption that TCAs are mostly prescribed for the treatment of pain [22] , and at doses lower than the DDD [24] . Although not licensed for this indication, amitriptyline, which was, in our study, the most prevalent agent, is considered first-line treatment for neuropathic pain in the National Institute for Health and Clinical Excellence (NICE) guidelines [58] . Duloxetine is also indicated for neuropathic pain and is registered for this indication [58] .
Although the first pharmacological choice to treat anxiety disorders chronically is an SSRI [59, 60] , in our study, physicians were more likely to prescribe a benzodiazepine on a chronic basis than an antidepressant. Benzodiazepines can be used for acute anxiety or can be co-administered for a short period of time (a maximum of 4 weeks) to overcome the delayed pharmacological effect of the antidepressant [59, 61, 62] . However, to avoid tolerance and dependence, this dual therapy should be tapered over time.
Characteristics Associated with Antidepressant Use
We found that older residents had lower antidepressant use. This is also mentioned in other antidepressant studies [9, 17] and with respect to other medication groups. This can be partly explained by the increasing incidence of dementia in older residents and the growing inability of residents to utter specific complaints (e.g. ''feeling depressed'') with deepening dementia. We also found that use of psychotropics and polypharmacy are inextricably linked, indicating the need for clinical practice guidelines and education focusing on initiation and reassessment of antidepressants and the use of psychotropics in general. Antiparkinson drugs were significantly associated with antidepressant use, which can be explained by the symptoms of parkinsonism; depression is a common neuropsychiatric manifestation in Parkinson's disease. As antidepressants may have sedative properties and are often used for the treatment of insomnia, it was no surprise that insomnia was correlated with antidepressant use and, more specifically, with antidepressant use for indications other than depression. Because in Belgium the differences in institutional characteristics between a private and public nursing home are small, we cannot explain the association between the private nursing homes and the elevated likelihood of receiving an antidepressant.
Depression and Dementia
In our study, in one third of the residents with noted dementia, depression was also reported. This rate is higher than the prevalence rate in other European countries [5, 63] and in the USA [64] . When analysing the different stages of disorientation (expression of dementia), we found that both the prevalence of depression and that of antidepressant use decreased with worsening disorientation. This could indicate the difficulty of diagnosing depression in cognitively impaired residents and a possible undertreatment in this specific patient group. However, a recent publication in the Lancet [65] suggested the absence of benefit of antidepressants in dementia compared with placebo and the increased risk of adverse events. The trial underscores the need to think about creative but evidencebased alternatives (such as psychosocial interventions) for the management of depression in people with dementia. But because of organizational and staffing problems, psychotherapy is not routinely available in Belgian nursing homes.
Conclusions
Antidepressants were used by 39.5 % of the residents. Overall, the quality of antidepressant prescribing in the Belgian nursing homes was found to be relatively satisfactory. Most of the residents with reported depression were treated according to evidence-based recommendations with SSRIs (mainly citalopram, sertraline and escitalopram) in dosages equal to or higher than the MED. Venlafaxine, not the first-choice drug in the older population, was used by one in ten residents and in dosages equal to or higher than the MED. All other antidepressants (TCAs, mirtazapine, trazodone) used for depression were dosed under the MED. In the indication of anxiety, most of the time, the physicians did not prescribe the recommended SSRIs; they preferred the chronic use of benzodiazepines.
A controversial issue is the prescribing of sedative antidepressants (mostly trazodone) for insomnia (13.4 %). A plausible explanation for this prescribing without clear evidence of efficacy and safety in frail older adults can be found in the reimbursed status of antidepressants and the relatively lower cost of trazodone in comparison with other sleeping pills.
